Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cardiome Pharma Corp (NASDAQ:CRME)

9.07
Delayed Data
As of Jul 31
 +0.07 / +0.78%
Today’s Change
5.84
Today|||52-Week Range
11.31
-1.95%
Year-to-Date

Today’s Trading

Previous close9.00
Today’s open9.01
Day’s range9.00 - 9.10
Volume14,460
Average volume (3 months)57,296
Market cap$151.0M
Dividend yield--
Data as of 3:54pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-402.70%
Earnings growth (this year)+68.37%
Earnings growth (next 5 years)--
Revenue growth (last year)+565.97%
P/E ratio--
Price/Sales4.98
Price/Book8.71

Competitors

 Today’s
change
Today’s
% change
GTXIGTX Inc+0.02+1.83%
GLYCGlycoMimetics Inc-0.17-2.23%
TNXPTonix Pharmaceutical...+0.28+3.44%
EPRSEPIRUS Biopharmaceut...+0.22+3.51%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$30.0M
Annual profit (last year)-$18.2M
Net profit margin-60.67%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
William L. Hunter
Chief Operating Officer
Sheila M. Grant
Corporate headquarters
Vancouver, British Columbia

Forecasts

Chart unavailable